Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
Immunotherapy in advanced gastric cancer, is it the future?
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2018.10.007
Advanced stage melanoma therapies: Detailing the present and exploring the future.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2018.11.002
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.05.012
Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.02.005
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.06.005
Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102860
Efficacy and safety of combination immunotherapy for malignant solid tumors: A systematic review and meta-analysis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.008
Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102830
Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.05.015
Unleash the power of the mighty T cells-basis of adoptive cellular therapy.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.01.015
Breast cancer risk of hormonal contraception: Counselling considering new evidence.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.03.001
Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102827
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102820
Effects of current parenteral nutrition treatment on health-related quality of life, physical function, nutritional status, survival and adverse events exclusively in patients with advanced cancer: A systematic literature review.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.014
Beta blockade as adjunctive breast cancer therapy: A review.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.006
Clinical implications of measurable residual disease in AML: Review of current evidence.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2018.11.010
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102858
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.03.012
Immunotherapy and urothelial carcinoma: An overview and future prospectives.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.08.005
Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2018.07.013
Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.07.002
The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.020
Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.08.007
Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.05.009
Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.05.002
Is health status impaired in childhood cancer survivors? A systematic review and meta-analysis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.07.008
The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.011
Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.021
Current opinions in immune checkpoint inhibitors rechallenge in solid cancers.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102816
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.01.011
Revisiting the impact of lifestyle on colorectal cancer risk in a gender perspective.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102834
Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.005
The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.04.015
Ovarian carcinosarcoma: Current developments and future perspectives.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2018.12.006
Germinal immunogenetics as a predictive factor for immunotherapy.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.06.013
Biosimilars in oncology: A decade of experience with granulocyte colony-stimulating factor and its implications for monoclonal antibodies.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.07.009
Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: A systematic review and network meta-analysis of 14,533 patients over 29 randomized clinical trials.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.07.001
Role of long non-coding RNAs in lymphoma: A systematic review and clinical perspectives.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.05.007
The treatment of rectal cancer with synchronous liver metastases: A matter of strategy.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.05.004
Immune check-point in glioblastoma multiforme.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.03.019
Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world series.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.05.006
Proportion of false-positive follow-up FDG-PET scans in lymphoma: Systematic review and meta-analysis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/J.CRITREVONC.2019.05.010
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2018.11.001
Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.01.005
Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102840
Helicobacter pylori: History and facts in Peru.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2018.12.005
Antineoplastic-related cardiovascular toxicity: A systematic review and meta-analysis in Asia.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.05.017
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102836
Evaluation of spin in oncology clinical trials.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102821
Childhood cancer, age at diagnosis and educational attainment: A meta-analysis.
来源期刊：Critical reviews in oncology/hematologyDOI：10.1016/j.critrevonc.2019.102838
